Loading…
Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases
Autoimmune diseases have a high prevalence in the population, and autoimmune thyroid disease (AITD) is one of the most common representatives. Thyroid autoantibodies are not only frequently detected in patients with AITD but also in subjects without manifest thyroid dysfunction. The high prevalence...
Saved in:
Published in: | Frontiers in immunology 2017-05, Vol.8, p.521 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c528t-7cf0126b1fd6b152a087fe38d88a9c1f7bbf1ddb2aef59a31164927c7410ffec3 |
---|---|
cites | cdi_FETCH-LOGICAL-c528t-7cf0126b1fd6b152a087fe38d88a9c1f7bbf1ddb2aef59a31164927c7410ffec3 |
container_end_page | |
container_issue | |
container_start_page | 521 |
container_title | Frontiers in immunology |
container_volume | 8 |
creator | Fröhlich, Eleonore Wahl, Richard |
description | Autoimmune diseases have a high prevalence in the population, and autoimmune thyroid disease (AITD) is one of the most common representatives. Thyroid autoantibodies are not only frequently detected in patients with AITD but also in subjects without manifest thyroid dysfunction. The high prevalence raises questions regarding a potential role in extra-thyroidal diseases. This review summarizes the etiology and mechanism of AITD and addresses prevalence of antibodies against thyroid peroxidase, thyroid-stimulating hormone receptor (TSHR), and anti-thyroglobulin and their action outside the thyroid. The main issues limiting the reliability of the conclusions drawn here include problems with different specificities and sensitivities of the antibody detection assays employed, as well as potential confounding effects of altered thyroid hormone levels, and lack of prospective studies. In addition to the well-known effects of TSHR antibodies on fibroblasts in Graves' disease (GD), studies speculate on a role of anti-thyroid antibodies in cancer. All antibodies may have a tumor-promoting role in breast cancer carcinogenesis despite anti-thyroid peroxidase antibodies having a positive prognostic effect in patients with overt disease. Cross-reactivity with lactoperoxidase leading to induction of chronic inflammation might promote breast cancer, while anti-thyroid antibodies in manifest breast cancer might be an indication for a more active immune system. A better general health condition in older women with anti-thyroid peroxidase antibodies might support this hypothesis. The different actions of the anti-thyroid antibodies correspond to differences in cellular location of the antigens, titers of the circulating antibodies, duration of antibody exposure, and immunological mechanisms in GD and Hashimoto's thyroiditis. |
doi_str_mv | 10.3389/fimmu.2017.00521 |
format | article |
fullrecord | <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_addb0c5781bf4fce8e1ec0ee45396544</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_addb0c5781bf4fce8e1ec0ee45396544</doaj_id><sourcerecordid>28536577</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-7cf0126b1fd6b152a087fe38d88a9c1f7bbf1ddb2aef59a31164927c7410ffec3</originalsourceid><addsrcrecordid>eNpVkctKAzEUhoMoKtq9K5kXmJrrJONCKN5BEKQuJWSSkzYynchkKvbtTVsrmkUuJ_m_kHwInRE8ZkzVFz4sFssxxUSOMRaU7KFjUlW8ZJTy_T_zIzRK6R3nxmvGmDhER1QJVgkpj9HbdL7qY3DFZDnENbALw-qyeIktFNEXk24I5bA7khdNdAFSEbpiFzSdK26_ht6UPxXTFjchgUmQTtGBN22C0c94gl7vbqfXD-XT8_3j9eSptIKqoZTWY0KrhniXO0ENVtIDU04pU1viZdN44lxDDXhRG0ZIxWsqreQEew-WnaDHLddF864_-rAw_UpHE_SmEPuZNv0QbAvaZA62QirSeO4tKCBgMQAXrK4E55l1tWV9LJsFOAtdflv7D_p_pwtzPYufWvD82VJlAN4CbB9T6sH_ZgnWa3N6Y06vzemNuRw5_3vnb2DniX0DeSaYWw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases</title><source>PubMed Central</source><creator>Fröhlich, Eleonore ; Wahl, Richard</creator><creatorcontrib>Fröhlich, Eleonore ; Wahl, Richard</creatorcontrib><description>Autoimmune diseases have a high prevalence in the population, and autoimmune thyroid disease (AITD) is one of the most common representatives. Thyroid autoantibodies are not only frequently detected in patients with AITD but also in subjects without manifest thyroid dysfunction. The high prevalence raises questions regarding a potential role in extra-thyroidal diseases. This review summarizes the etiology and mechanism of AITD and addresses prevalence of antibodies against thyroid peroxidase, thyroid-stimulating hormone receptor (TSHR), and anti-thyroglobulin and their action outside the thyroid. The main issues limiting the reliability of the conclusions drawn here include problems with different specificities and sensitivities of the antibody detection assays employed, as well as potential confounding effects of altered thyroid hormone levels, and lack of prospective studies. In addition to the well-known effects of TSHR antibodies on fibroblasts in Graves' disease (GD), studies speculate on a role of anti-thyroid antibodies in cancer. All antibodies may have a tumor-promoting role in breast cancer carcinogenesis despite anti-thyroid peroxidase antibodies having a positive prognostic effect in patients with overt disease. Cross-reactivity with lactoperoxidase leading to induction of chronic inflammation might promote breast cancer, while anti-thyroid antibodies in manifest breast cancer might be an indication for a more active immune system. A better general health condition in older women with anti-thyroid peroxidase antibodies might support this hypothesis. The different actions of the anti-thyroid antibodies correspond to differences in cellular location of the antigens, titers of the circulating antibodies, duration of antibody exposure, and immunological mechanisms in GD and Hashimoto's thyroiditis.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2017.00521</identifier><identifier>PMID: 28536577</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>autoimmune thyroiditis ; Graves’ orbitopathy ; Immunology ; thyroglobulin ; thyroid autoantibodies ; thyroid peroxidase ; thyroid-stimulating hormone receptor</subject><ispartof>Frontiers in immunology, 2017-05, Vol.8, p.521</ispartof><rights>Copyright © 2017 Fröhlich and Wahl. 2017 Fröhlich and Wahl</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-7cf0126b1fd6b152a087fe38d88a9c1f7bbf1ddb2aef59a31164927c7410ffec3</citedby><cites>FETCH-LOGICAL-c528t-7cf0126b1fd6b152a087fe38d88a9c1f7bbf1ddb2aef59a31164927c7410ffec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422478/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422478/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28536577$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fröhlich, Eleonore</creatorcontrib><creatorcontrib>Wahl, Richard</creatorcontrib><title>Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Autoimmune diseases have a high prevalence in the population, and autoimmune thyroid disease (AITD) is one of the most common representatives. Thyroid autoantibodies are not only frequently detected in patients with AITD but also in subjects without manifest thyroid dysfunction. The high prevalence raises questions regarding a potential role in extra-thyroidal diseases. This review summarizes the etiology and mechanism of AITD and addresses prevalence of antibodies against thyroid peroxidase, thyroid-stimulating hormone receptor (TSHR), and anti-thyroglobulin and their action outside the thyroid. The main issues limiting the reliability of the conclusions drawn here include problems with different specificities and sensitivities of the antibody detection assays employed, as well as potential confounding effects of altered thyroid hormone levels, and lack of prospective studies. In addition to the well-known effects of TSHR antibodies on fibroblasts in Graves' disease (GD), studies speculate on a role of anti-thyroid antibodies in cancer. All antibodies may have a tumor-promoting role in breast cancer carcinogenesis despite anti-thyroid peroxidase antibodies having a positive prognostic effect in patients with overt disease. Cross-reactivity with lactoperoxidase leading to induction of chronic inflammation might promote breast cancer, while anti-thyroid antibodies in manifest breast cancer might be an indication for a more active immune system. A better general health condition in older women with anti-thyroid peroxidase antibodies might support this hypothesis. The different actions of the anti-thyroid antibodies correspond to differences in cellular location of the antigens, titers of the circulating antibodies, duration of antibody exposure, and immunological mechanisms in GD and Hashimoto's thyroiditis.</description><subject>autoimmune thyroiditis</subject><subject>Graves’ orbitopathy</subject><subject>Immunology</subject><subject>thyroglobulin</subject><subject>thyroid autoantibodies</subject><subject>thyroid peroxidase</subject><subject>thyroid-stimulating hormone receptor</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkctKAzEUhoMoKtq9K5kXmJrrJONCKN5BEKQuJWSSkzYynchkKvbtTVsrmkUuJ_m_kHwInRE8ZkzVFz4sFssxxUSOMRaU7KFjUlW8ZJTy_T_zIzRK6R3nxmvGmDhER1QJVgkpj9HbdL7qY3DFZDnENbALw-qyeIktFNEXk24I5bA7khdNdAFSEbpiFzSdK26_ht6UPxXTFjchgUmQTtGBN22C0c94gl7vbqfXD-XT8_3j9eSptIKqoZTWY0KrhniXO0ENVtIDU04pU1viZdN44lxDDXhRG0ZIxWsqreQEew-WnaDHLddF864_-rAw_UpHE_SmEPuZNv0QbAvaZA62QirSeO4tKCBgMQAXrK4E55l1tWV9LJsFOAtdflv7D_p_pwtzPYufWvD82VJlAN4CbB9T6sH_ZgnWa3N6Y06vzemNuRw5_3vnb2DniX0DeSaYWw</recordid><startdate>20170509</startdate><enddate>20170509</enddate><creator>Fröhlich, Eleonore</creator><creator>Wahl, Richard</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170509</creationdate><title>Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases</title><author>Fröhlich, Eleonore ; Wahl, Richard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-7cf0126b1fd6b152a087fe38d88a9c1f7bbf1ddb2aef59a31164927c7410ffec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>autoimmune thyroiditis</topic><topic>Graves’ orbitopathy</topic><topic>Immunology</topic><topic>thyroglobulin</topic><topic>thyroid autoantibodies</topic><topic>thyroid peroxidase</topic><topic>thyroid-stimulating hormone receptor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fröhlich, Eleonore</creatorcontrib><creatorcontrib>Wahl, Richard</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fröhlich, Eleonore</au><au>Wahl, Richard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2017-05-09</date><risdate>2017</risdate><volume>8</volume><spage>521</spage><pages>521-</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Autoimmune diseases have a high prevalence in the population, and autoimmune thyroid disease (AITD) is one of the most common representatives. Thyroid autoantibodies are not only frequently detected in patients with AITD but also in subjects without manifest thyroid dysfunction. The high prevalence raises questions regarding a potential role in extra-thyroidal diseases. This review summarizes the etiology and mechanism of AITD and addresses prevalence of antibodies against thyroid peroxidase, thyroid-stimulating hormone receptor (TSHR), and anti-thyroglobulin and their action outside the thyroid. The main issues limiting the reliability of the conclusions drawn here include problems with different specificities and sensitivities of the antibody detection assays employed, as well as potential confounding effects of altered thyroid hormone levels, and lack of prospective studies. In addition to the well-known effects of TSHR antibodies on fibroblasts in Graves' disease (GD), studies speculate on a role of anti-thyroid antibodies in cancer. All antibodies may have a tumor-promoting role in breast cancer carcinogenesis despite anti-thyroid peroxidase antibodies having a positive prognostic effect in patients with overt disease. Cross-reactivity with lactoperoxidase leading to induction of chronic inflammation might promote breast cancer, while anti-thyroid antibodies in manifest breast cancer might be an indication for a more active immune system. A better general health condition in older women with anti-thyroid peroxidase antibodies might support this hypothesis. The different actions of the anti-thyroid antibodies correspond to differences in cellular location of the antigens, titers of the circulating antibodies, duration of antibody exposure, and immunological mechanisms in GD and Hashimoto's thyroiditis.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>28536577</pmid><doi>10.3389/fimmu.2017.00521</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-3224 |
ispartof | Frontiers in immunology, 2017-05, Vol.8, p.521 |
issn | 1664-3224 1664-3224 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_addb0c5781bf4fce8e1ec0ee45396544 |
source | PubMed Central |
subjects | autoimmune thyroiditis Graves’ orbitopathy Immunology thyroglobulin thyroid autoantibodies thyroid peroxidase thyroid-stimulating hormone receptor |
title | Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A25%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thyroid%20Autoimmunity:%20Role%20of%20Anti-thyroid%20Antibodies%20in%20Thyroid%20and%20Extra-Thyroidal%20Diseases&rft.jtitle=Frontiers%20in%20immunology&rft.au=Fr%C3%B6hlich,%20Eleonore&rft.date=2017-05-09&rft.volume=8&rft.spage=521&rft.pages=521-&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2017.00521&rft_dat=%3Cpubmed_doaj_%3E28536577%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c528t-7cf0126b1fd6b152a087fe38d88a9c1f7bbf1ddb2aef59a31164927c7410ffec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/28536577&rfr_iscdi=true |